Omada Health Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2025
Omada Health (NASDAQ:OMDA) was upgraded by analysts at Wells Fargo & Company to a "hold" rating.
Omada Health (NASDAQ:OMDA) was given a new $29.00 price target on by analysts at The Goldman Sachs Group, Inc..
Omada Health's GLP-1 Behavior Change Companion Programs Help Drive Lasting, Long-Term Weight Loss [Yahoo! Finance]
Omada Health (NASDAQ:OMDA) was given a new $17.00 price target on by analysts at Wells Fargo & Company.